ECG telemetry devices market seen reaching $6.72 billion by 2030

The global electrocardiogram telemetry devices market reached $4.5 billion in 2025 and is forecast to climb to $6.72 billion by 2030, driven by rising cardiovascular disease rates, remote monitoring demand and new wireless and AI-enabled tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - ECG telemetry devices support continuous heart monitoring, which can speed diagnosis and treatment for arrhythmias, heart attacks and other cardiovascular disorders. - Growth in the market tracks with the rising burden of cardiovascular disease and the shift toward remote and home-based care. - The segment is becoming more important as healthcare systems look for tools that extend monitoring beyond the hospital.

What happened: - The Business Research Company projected the global electrocardiogram (ECG) telemetry devices market will rise from $4.5 billion in 2025 to $4.88 billion in 2026. - The market is forecast to reach $6.72 billion by 2030. - The report estimates 8.6% CAGR from 2025 to 2026 and 8.3% CAGR through 2030. - The company released the outlook from London on Aug. 5, 2026. - The report also offered a free sample and the full market report.

The details: - ECG telemetry devices continuously monitor and record the heart's electrical signals over time. - The devices are used in inpatient and outpatient settings. - They help healthcare professionals respond in real time and improve patient outcomes. - Market growth in the historical period was driven by limited availability of remote monitoring technologies, heavy reliance on hospital-based ECG systems, rising cardiovascular disease rates, growth in outpatient care and greater awareness of arrhythmia management. - Future growth is expected to come from wireless mobile cardiac telemetry, miniaturized implantable loop recorders, AI and predictive analytics, home healthcare expansion and cloud-enabled ECG monitoring platforms. - The report says the devices are important for continuous monitoring that supports remote and home-based healthcare models. - The devices also improve the effectiveness of implantable cardiac devices and help enable faster emergency response. - In January 2024, the American Heart Association reported the U.S. age-adjusted cardiovascular death rate rose to 233.3 per 100,000 population, up 4.0% from 224.4 a year earlier. - That trend adds pressure for more advanced monitoring tools. - In 2025, North America held the largest market share. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and updated technology and future trend analysis.

Between the lines: - The forecast suggests ECG telemetry is moving from a niche monitoring category into a broader digital care infrastructure layer. - The mix of wireless devices, AI tools and cloud platforms points to a market shaped by software as much as hardware. - Regional leadership is still anchored in North America, but the fastest growth outlook in Asia-Pacific suggests demand is widening globally.

What's next: - The market is expected to keep expanding as care shifts toward earlier detection, remote monitoring and lower-cost outpatient management. - Adoption of mobile telemetry, implantable recorders and cloud-based monitoring should help determine which companies gain share through 2030. - The report's expanded analytics tools may help buyers and vendors identify the strongest regional and technology opportunities.